Stock data
Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics, Inc. (ARTV) reported revenue of US$0.00M and net income of -US$83.86M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$89.81M | -US$83.86M | — |
| 2024 | US$0.25M | — | -US$67.28M | -US$65.37M | — |
| 2023 | US$32.92M | — | -US$30.67M | -US$28.72M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$25.00M | — |
| 2026-03-31 | — | -US$23.52M | — |
| 2025-12-31 | — | -US$20.77M | — |
| 2025-09-30 | — | -US$21.53M | — |
| 2025-06-30 | — | -US$21.25M | — |
| 2025-03-31 | — | -US$20.31M | — |
| 2024-12-31 | — | -US$16.09M | — |
| 2024-09-30 | — | -US$17.47M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.